In this episode of Cures & Capital, Dr. Sheila Gujrathi — biotech entrepreneur, investor, and former CEO of Gossamer Bio — shares her perspective on how to elevate female leaders and underrepresented voices in biopharma. She discusses lessons from her 25+ years leading companies and investments, and why inclusive leadership is key to innovation and value creation. We also dive into her book, The Mirror Effect, and her mission to inspire the next generation of women in biotech. Check out S...
All content for Cures & Capital is the property of Martin Slezak and Simon Birksø and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
In this episode of Cures & Capital, Dr. Sheila Gujrathi — biotech entrepreneur, investor, and former CEO of Gossamer Bio — shares her perspective on how to elevate female leaders and underrepresented voices in biopharma. She discusses lessons from her 25+ years leading companies and investments, and why inclusive leadership is key to innovation and value creation. We also dive into her book, The Mirror Effect, and her mission to inspire the next generation of women in biotech. Check out S...
Deborah Dunsire on leading in today’s biopharma landscape
Cures & Capital
1 hour 4 minutes
2 months ago
Deborah Dunsire on leading in today’s biopharma landscape
In this episode, we talk to Deborah Dunsire, board chair at Neurvati Neurosciences, multiple times board member, and a former CEO of Lundbeck. With more than 3 decades of experience, Deborah has navigated organizations of every size through change, uncertainty, and opportunity. We explore what it takes to lead in today’s biopharma landscape - from rolling up your sleeves in biotech to streamlining decisions in big pharma, and from balancing short-term survival in a capital-constrained enviro...
Cures & Capital
In this episode of Cures & Capital, Dr. Sheila Gujrathi — biotech entrepreneur, investor, and former CEO of Gossamer Bio — shares her perspective on how to elevate female leaders and underrepresented voices in biopharma. She discusses lessons from her 25+ years leading companies and investments, and why inclusive leadership is key to innovation and value creation. We also dive into her book, The Mirror Effect, and her mission to inspire the next generation of women in biotech. Check out S...
